Navigation Links
New Model Provides Insights Into Intravenous and Subcutaneous Immunoglobulin Pharmacokinetics in Patients With Primary Immunodeficiencies
Date:3/19/2011

rivigen.com/">first proline-stabilized intravenous immunoglobulin. CSL Behring manufactures Hizentra at its state-of-the art facility in Bern, Switzerland, where advanced technologies are applied to further ensure product safety and ample supply. This facility represents the long-term commitment of CSL Behring to global Ig markets.

Important Safety InformationHizentra®, Immune Globulin Subcutaneous (Human), is indicated as replacement therapy for the treatment of patients with primary humoral immunodeficiency.

Hizentra is contraindicated in individuals with a history of anaphylactic or severe systemic response to immune globulin preparations or components of Hizentra, and in persons with selective immunoglobulin A deficiency who have known antibody against IgA and a history of hypersensitivity. If anaphylactic reactions are suspected, administration should be discontinued immediately and the patient treated as medically appropriate. Because Hizentra contains the stabilizer L-proline, it is also contraindicated in patients with hyperprolinemia.

Hizentra should be administered subcutaneously only.

Hizentra is derived from human plasma. The risk of transmission of infectious agents including viruses and, theoretically, the Creutzfeldt-Jakob disease (CJD) agent, cannot be eliminated completely.

The most common drug-related adverse reactions, observed in 5 percent or more of subjects in the clinical study, were local injection-site reactions, headache, vomiting, pain, and fatigue.

Monitor patients for reactions associated with IVIg treatment that might occur with Hizentra, including renal dysfunction/failure, thrombotic events, aseptic meningitis syndrome (AMS), hemolysis and transfusion-related acute lung injury (TRALI).

For full prescribing information, visit www.hizentra.com/consumer/prescribing-information.aspx.

'/>"/>

SOURCE CSL Behring
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. PAREXEL Experts To Address Best-Practice Strategic Partnership Models To Increase Operating Efficiency, Development Effectiveness at Partnerships in Clinical Trials
2. FDA Approves Revised Alphanate® Labeling to Include Reduced Infectivity of an Experimental Model Agent for vCJD
3. S*BIOs Novel Dual mTOR/PI3 Kinase Inhibitor SB2343 Demonstrates Excellent PK/PD Properties Leading to Significant Anti-Tumor Efficacy in Xenograft Models
4. Reportlinker Adds Drug Device Combination Market to 2016 - Technological Convergence to be the New Business Model for Growth and Profitability
5. Nonin Medical, Inc. Launches New WristOx2™, Model 3150 in U.S. and Canada
6. Maldonado Medicals Green Initiative, a Model for the American Small Business
7. MedWOW Adds Parts Finder Service and Enhances Business Model
8. CareFusion Recall of Alaris PC Units Model 8015 Classified as Class I Recall
9. Transposagen Announces Exclusive License with Charles River Laboratories for p53 and Bcrp TGEM™ Knockout Rat Models
10. Reportlinker Adds Sales Force Effectiveness in Pharmaceuticals - Cost Pressures Increase Pharmaceutical Companies Adoption of New Sales Models and Technologies
11. Tengion Presents New Data Demonstrating Functional Regeneration in a Diabetic Chronic Kidney Failure Model at the International Society for Cellular Therapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... PITTSBURGH , July 30, 2014   ... Markets Groups Inc.: OTC Pink: UPZS), a Delaware ... a distribution agreement with Larasan Pharmaceutical Corporation ("Larasan"), a ... products.  According to the agreement, US-based Larasan will ... gourmet 6" frozen pizza through Larasan,s vast distribution ...
(Date:7/30/2014)... Germany , July 30, 2014  invendo medical ... computer-assisted ("robotic") colonoscopy system, today announced the appointment of ... device executive, as a new member of its supervisory ... respected global visionary in the medical device industry. In ... Chief Executive Officer at Given Imaging Ltd. (NASDAQ/TASE: GIVN), ...
(Date:7/30/2014)... PARIS , July 30, 2014  Regeneron ... (EURONEXT: SAN and NYSE: SNY ) today ... alirocumab in people with hypercholesterolemia met their primary efficacy ... low-density lipoprotein cholesterol (LDL-C) at 24 weeks compared to ... antibody targeting PCSK9 (proprotein convertase subtilisin/kexin type 9). ...
Breaking Medicine Technology:Unique Pizza and Subs Announces Asian Distribution Agreement with Larasan Pharmaceutical Corporation 2Unique Pizza and Subs Announces Asian Distribution Agreement with Larasan Pharmaceutical Corporation 3invendo medical Appoints Nachum (Homi) Shamir To The Company's Board Of Directors 2invendo medical Appoints Nachum (Homi) Shamir To The Company's Board Of Directors 3Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 2Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 3Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 4Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 5Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 6Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 7Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 8
... LIUZHOU CITY, China , July 19 ... CNBI), ("China BCT" or the,"Company"), a leading pharmaceutical distributor, ... Province , China , today,announced that on ... Public,Accountants, A Professional Corporation, Glendale, California ("PKF,California"), ...
... 19 "This is a historic day for HIV prevention research. ... gel can help to prevent sexual transmission of HIV infection," said AVAC ... landmark microbicide trial presented today at the International AIDS Conference in ... "We believe ...
Cached Medicine Technology:China BCT Announces Auditor Change Within PKF Network 2China BCT Announces Auditor Change Within PKF Network 3AVAC Praises CAPRISA 004 Trial Collaborators and Participants for Historic Study - Trial Confirms Promise of ARV-Based Microbicides 2AVAC Praises CAPRISA 004 Trial Collaborators and Participants for Historic Study - Trial Confirms Promise of ARV-Based Microbicides 3AVAC Praises CAPRISA 004 Trial Collaborators and Participants for Historic Study - Trial Confirms Promise of ARV-Based Microbicides 4
(Date:7/30/2014)... Colorado (PRWEB) July 30, 2014 Daily Gossip ... attacks can occur easily. A panic attack is a feeling ... various factors. There are a series of symptoms that sufferers ... This includes shortness of breath, stress or anxiety. Naturally, panic ... fast and effective way to overcome them. , The 60 ...
(Date:7/30/2014)... MyMobileUniversity (MMU) is a global initiative ... award winning mobile and web based learning company that ... , MyMobileUni.com’s platform makes it a one-stop centre to ... links to the world’s leading Massive Open Online Courses ... from all over the world who have content that ...
(Date:7/30/2014)... July 30, 2014 Nationally recognized leader ... ANEF, who since September 2013 has served as president ... the new dean of the College of Nursing at ... marries her leadership of the NLN, as the nation's ... top-ranked academic nursing and research institutions in the country. ...
(Date:7/30/2014)... July 30, 2014 Within weeks freshman will begin ... promise. Each hopes this will be a time of growth and ... each to pause; it may not be as easy as it ... students will switch their major at least once and many will ... energy and the costs are exacerbated when switching in the later ...
(Date:7/30/2014)... Throughout the month of August, Restore ... cancer screenings. Using a new technological tool called The ... disease in its early stages. , Oral cancer can ... throat and other areas in and around the mouth. ... Ends Results (SEER) program, 30 percent of oral cancers ...
Breaking Medicine News(10 mins):Health News:60 Second Panic Solution Review Reveals Unique Way to Stop Panic Attacks 2Health News:MyMobileUniversity Inviting Individuals, Who Are Passionate about the Universal Right to Education, to Come on Board as Goodwill Ambassadors 2Health News:MyMobileUniversity Inviting Individuals, Who Are Passionate about the Universal Right to Education, to Come on Board as Goodwill Ambassadors 3Health News:National League for Nursing Congratulates League President Marsha Adams on Appointment as Dean of College of Nursing at University of Alabama-Huntsville 2Health News:National League for Nursing Congratulates League President Marsha Adams on Appointment as Dean of College of Nursing at University of Alabama-Huntsville 3Health News:Advice to College Freshman from Author Garrett Miller 2Health News:Advice to College Freshman from Author Garrett Miller 3Health News:Restore Dental Offers Complimentary Oral Cancer Screenings in August 2
... all over the world gathered at the Gibson Hall ... Journal (GCPj) Awards. Opening,this landmark event, Chairman of the ... awards were a most important celebration,of innovation and enterprise ... become a traditional event in the public health calendar", ...
... For the first time,high definition (HD) video footage of ... and fertility specialist at Syosset and North Shore,University hospitals, ... 16 on the National Geographic Channel in stories that ... body. Dr. Palter is internationally recognized for his ...
... WASHINGTON, Sept. 7 The Sudden Cardiac Arrest,Association (SCAA) ... "We are excited to have Chris join SCAA as ... membership base, and work toward our goal of,eliminating preventable ... Richard Brown, chair of the SCAA Board of Directors.,"Advancements ...
... of Military and Veterans Affairs today dedicated a ... and,Sailors, Home., "With the completion of this ... for Pennsylvania,s 1.1 million veterans who,have served so ... Gen.,Jessica L. Wright, state adjutant general. "Now, all ...
... those with no asthma history, study finds , FRIDAY, Sept. ... have what,s known as exercise-induced asthma, even though they may ... shows. , Previous research in Olympic athletes has also shown ... in this study, because many of the reported severe episodes ...
... with Heparin Bioactive Surface Offers Safe, ... Effective Alternative to Surgery, ... Hospital became the world,s first physician on Wednesday, Aug.,29, to ... a new,device that improves outcomes, speeds recovery and may minimize ...
Cached Medicine News:Health News:Good Clinical Practice Journal Awards: Winners Announced 2Health News:Good Clinical Practice Journal Awards: Winners Announced 3Health News:Good Clinical Practice Journal Awards: Winners Announced 4Health News:Revolutionary HD Surgical Footage from North Shore-LIJ Surgeon to be Broadcast for the First Time on ABC's 20/20, National Geographic Channel 2Health News:Corporate and Political PR Pro to Lead Sudden Cardiac Arrest Association 2Health News:1 in 3 Varsity Athletes Has Exercise-Induced Asthma 2Health News:Riverside First to Offer New Treatment for Peripheral Arterial Disease 2Health News:Riverside First to Offer New Treatment for Peripheral Arterial Disease 3
InterVascular HemaCarotid Patch product line offers the vascular surgeon a complete range of knitted, collagen coated patches in a wide range of sizes for carotid endarterectomy and angioplasty witho...
The VasoSeal Low Profile device is designed for smaller sheath angiography procedures. VasoSeal Low Profile. Seal your arterial punctures with confidence....
The VasoSeal Low Profile device is designed for smaller sheath angiography procedures. VasoSeal Low Profile. Seal your arterial punctures with confidence....
D-Stat Radial is a dry version of the D-Stat together with a compression band, and is designed for the control of surface bleeding from vascular access sites, including the sites on the radial artery...
Medicine Products: